Moreover, NK-92 cells, a CD5-negative NK cell line, were utilized to enhance cytotoxicity against T-cell leukemia via CD5-CAR, which significantly improved survival in a T-ALL xenograft model. Here, CD5 is linked to acute lymphoblastic leukemia.